Cancer diagnosis using label-free SERS-based exosome analysis

Theranostics. 2024 Feb 24;14(5):1966-1981. doi: 10.7150/thno.92621. eCollection 2024.

Abstract

Exosomes, carrying distinctive biomolecules reflective of their parent cell's status and origin, show promise as liquid biopsy biomarkers for cancer diagnosis. However, their clinical translation remains challenging due to their relatively low concentration in body fluids. Surface-Enhanced Raman spectroscopy (SERS) has recently gained significant attention as a label-free and sensitive technique for exosome analysis. This review explores label-free SERS for exosome detection, covering exosome isolation and characterization methods, advancements in SERS substrates, and fingerprint analysis techniques using machine learning. Furthermore, we emphasize the challenges and offer insights into the future prospects of SERS-based exosome analysis to enhance cancer diagnosis.

Keywords: Cancer diagnosis; Exosome; Raman Spectroscopy; SERS; label-free SERS.

Publication types

  • Review

MeSH terms

  • Biomarkers / analysis
  • Exosomes* / chemistry
  • Humans
  • Liquid Biopsy / methods
  • Neoplasms* / diagnosis
  • Spectrum Analysis, Raman / methods

Substances

  • Biomarkers